Inovio Pharmaceuticals, Inc. (INO) Posts Q2 Loss of 2c/Share
Tweet
Share
E-mailGet Alerts INO Hot Sheet
Price: $1.15 --0%
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
HSAI, SYRS, EGRX, More
Financial Fact:
Loss from investment in affiliated entity: -958.14K
Today's EPS Names:
HSAI, SYRS, EGRX, More
Join SI Premium – FREE
Inovio Pharmaceuticals, Inc. (NYSE: INO) reported Q2 EPS of ($0.02), $0.03 better than the analyst estimate of ($0.05). Revenue for the quarter came in at $2.4 million versus the consensus estimate of $1.79 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- H.C. Wainwright Reiterates Neutral Rating on Inovio Pharmaceuticals (INO)
- Pony AI (PONY) Reports Revenue Above Estimates
- Baidu (BIDU) Misses Q2 EPS by 262c, misses on revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
